Review



inactive control variant  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Addgene inc inactive control variant
    Inactive Control Variant, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/pSBbi-Pur-Lyn-AktAR2-EV-D+(Plasmid+%23125200)/pm41795331-130-24-28
    Average 93 stars, based on 3 article reviews
    inactive control variant - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Negative Control:

    Article Title: Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells.
    Article Snippet: .. As a negative control, an identical construct containing a catalytically inactive human TET1CD domain (Addgene # 129028) was generated and termed pdTET (see Fig. S1c). ..

    Article Title: Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells
    Article Snippet: .. As a negative control, an identical construct containing a catalytically inactive human TET1CD domain (Addgene # 129028) was generated and termed pdTET (see Fig. c). ..

    Construct:

    Article Title: Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells.
    Article Snippet: .. As a negative control, an identical construct containing a catalytically inactive human TET1CD domain (Addgene # 129028) was generated and termed pdTET (see Fig. S1c). ..

    Article Title: Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells
    Article Snippet: .. As a negative control, an identical construct containing a catalytically inactive human TET1CD domain (Addgene # 129028) was generated and termed pdTET (see Fig. c). ..

    Generated:

    Article Title: Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells.
    Article Snippet: .. As a negative control, an identical construct containing a catalytically inactive human TET1CD domain (Addgene # 129028) was generated and termed pdTET (see Fig. S1c). ..

    Article Title: Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells
    Article Snippet: .. As a negative control, an identical construct containing a catalytically inactive human TET1CD domain (Addgene # 129028) was generated and termed pdTET (see Fig. c). ..

    Control:

    Article Title: Systematic comparison of dCas9-based DNA methylation epimodifiers over time indicates efficient on-target and widespread off-target effects
    Article Snippet: Finally, after removing the Puro from the pdCas9-DNMT3A-Puro plasmid by EcoRI digestion and re-ligation, the CMV-GFP-T2A-Puro cassette was cloned on the pdCas9-DNMT3A plasmid (M3-dCas9-3A, Addgene #220237). .. The same procedure was applied to the control tool, consisting of dCas9 fused with the inactive DNMT3A (M3-dCAS9-DNMT3A, Addgene #220237). .. M3-dCAS9-DNMT3A-DNMT3A (dCas9-3A-3A, Addgene #218776) plasmid made by the amplification of the human DNMT3A catalytic domain from the pdCas9-DNMT3A-EGFP (Addgene #71666) plasmid using the primers containing the FseI restriction sites.

    Article Title: Comprehensive profiling of CRISPR/dCas9 epigenome editors indicates a complex link between on and off target effects.
    Article Snippet: Finally, after removing the Puro from the pdCas9DNMT3A-Puro plasmid by EcoRI digestion and re-ligation, the CMV-GFP-T2A-Puro cassette was cloned on the pdCas9-DNMT3A plasmid (M3-dCas9-3A, Addgene #220237). .. The same procedure was applied to the control tool, consisting of dCas9 fused with the inactive DNMT3A (M3-dCAS9DNMT3A, Addgene #220237). .. M3-dCAS9-DNMT3A-DNMT3A (dCas9-3A3A, Addgene #218776) plasmid made by the amplification of the human DNMT3A catalytic domain from the pdCas9DNMT3A-EGFP (Addgene #71666) plasmid using the primers containing the FseI restriction sites.

    Article Title: Noble metal/dextran-graft-polyacrylamide branched polymer nanocomposites induce ROS-dependent apoptosis in diffuse large B-cell lymphoma cells.
    Article Snippet: .. Oci-Ly7 cells were electroporated using the Neon Transfection System (Thermo Fisher Scientific) with either an active AKT reporter (pSBbi-Pur-Lyn-AktAR2-EV, Addgene plasmid #125199) or an inactive control variant (pSBbiPur-Lyn-AktAR2-EV-D, Addgene plasmid #125200), co-transfected with the SB100X transposase plasmid (pCMV(CAT) T7-SB100, Addgene plasmid #34879). ..

    other:

    Article Title: Increased SIRT3 combined with PARP inhibition rescues motor function of SBMA mice
    Article Snippet: Human SIRT3 WT (Addgene), human SIRT3-H248Y (deacetylase inactive) (Addgene), or an empty vector (pcDNA4/myc-His B backbone) control constructs were stably transfected into AR112Q PC12 cells with Lipofectamine 2000 (Invitrogen).

    Article Title: Mutational scanning of CRX classifies clinical variants and reveals biochemical properties of the transcriptional effector domain.
    Article Snippet: 529 Selected clones were co-transfected with 400 ng Addgene #11916 and 400 ng of 530 either pJLS99, pJLS100, or pJLS101, plasmids carrying wild-type CRX, the p.R90W 531 hypomorphic CRX variant, or miRFP670 (a transcriptionally inactive control protein), 532 25 respectively.

    Transfection:

    Article Title: Noble metal/dextran-graft-polyacrylamide branched polymer nanocomposites induce ROS-dependent apoptosis in diffuse large B-cell lymphoma cells.
    Article Snippet: .. Oci-Ly7 cells were electroporated using the Neon Transfection System (Thermo Fisher Scientific) with either an active AKT reporter (pSBbi-Pur-Lyn-AktAR2-EV, Addgene plasmid #125199) or an inactive control variant (pSBbiPur-Lyn-AktAR2-EV-D, Addgene plasmid #125200), co-transfected with the SB100X transposase plasmid (pCMV(CAT) T7-SB100, Addgene plasmid #34879). ..

    Plasmid Preparation:

    Article Title: Noble metal/dextran-graft-polyacrylamide branched polymer nanocomposites induce ROS-dependent apoptosis in diffuse large B-cell lymphoma cells.
    Article Snippet: .. Oci-Ly7 cells were electroporated using the Neon Transfection System (Thermo Fisher Scientific) with either an active AKT reporter (pSBbi-Pur-Lyn-AktAR2-EV, Addgene plasmid #125199) or an inactive control variant (pSBbiPur-Lyn-AktAR2-EV-D, Addgene plasmid #125200), co-transfected with the SB100X transposase plasmid (pCMV(CAT) T7-SB100, Addgene plasmid #34879). ..

    Variant Assay:

    Article Title: Noble metal/dextran-graft-polyacrylamide branched polymer nanocomposites induce ROS-dependent apoptosis in diffuse large B-cell lymphoma cells.
    Article Snippet: .. Oci-Ly7 cells were electroporated using the Neon Transfection System (Thermo Fisher Scientific) with either an active AKT reporter (pSBbi-Pur-Lyn-AktAR2-EV, Addgene plasmid #125199) or an inactive control variant (pSBbiPur-Lyn-AktAR2-EV-D, Addgene plasmid #125200), co-transfected with the SB100X transposase plasmid (pCMV(CAT) T7-SB100, Addgene plasmid #34879). ..



    Similar Products

    inactive control variant  (Addgene inc)
    93
    Addgene inc inactive control variant
    Inactive Control Variant, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/pSBbi-Pur-Lyn-AktAR2-EV-D+(Plasmid+%23125200)/pm41795331-130-24-28
    Average 93 stars, based on 1 article reviews
    inactive control variant - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    inactive control compound nvs pak1 c  (Tocris)
    93
    Tocris inactive control compound nvs pak1 c
    Inactive Control Compound Nvs Pak1 C, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/NVS+PAK1+C/pmc12741935-66-13-30
    Average 93 stars, based on 1 article reviews
    inactive control compound nvs pak1 c - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    inactive control compoundnvs pak1 c  (Tocris)
    93
    Tocris inactive control compoundnvs pak1 c
    Inactive Control Compoundnvs Pak1 C, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/NVS+PAK1+C/pm41451871-42-11-27
    Average 93 stars, based on 1 article reviews
    inactive control compoundnvs pak1 c - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    electromyography (emg) research  (MyoLearn)
    99
    MyoLearn electromyography (emg) research
    Electromyography (Emg) Research, supplied by MyoLearn, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/Electromyography+(EMG)+Research/custom%40emg%4010%2E3390%2Fjcm14248677
    Average 99 stars, based on 1 article reviews
    electromyography (emg) research - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    pkcε inactive peptide, negative control  (Millipore)
    90
    Millipore pkcε inactive peptide, negative control
    <t>PKC</t> mediates a T channel gain of function during alcohol withdrawal. (A–C) Representative traces of T-type current inactivation curves for (A) Air, (B) WD, and (C) WD + PKC (−) groups, respectively, elicited at −50 mV from holding potentials ranging from −135 to −60 mV for 1 s (inset). (D, E) Alcohol WD produced a significant depolarizing shift in the inactivation curve of native T-type calcium current. The depolarizing shift was blocked by PKC peptide inhibitors, including PKC epsilon-specific inhibitors. (F) V 50 derived from the inactivation curve ~5 h. into the 4th alcohol WD in C57BL/6 mice was analyzed. The significant depolarizing shift for V 50 was blocked by the PKC peptide inhibitor (PKC (−), 10 μM). This inhibition was mimicked by specific PKCε isoform inhibitors (#530993, 539522; 5 μM) but not a PKCε translocation inhibitor inactive <t>peptide</t> <t>(#539542;</t> 5 μM). All drugs were delivered through the internal pipette solution. Statistics for V 50 showed F (6, 73) = 3.87, p = 0.0021 (One-Way ANOVA). In the plot * indicates p <0.05 and ** indicates p <0.01.
    Pkcε Inactive Peptide, Negative Control, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/pkc%CE%B5+translocation+inhibitor+peptide/pmc11807373-2-3-1
    Average 90 stars, based on 1 article reviews
    pkcε inactive peptide, negative control - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    inactive control  (MedChemExpress)
    92
    MedChemExpress inactive control
    <t>PKC</t> mediates a T channel gain of function during alcohol withdrawal. (A–C) Representative traces of T-type current inactivation curves for (A) Air, (B) WD, and (C) WD + PKC (−) groups, respectively, elicited at −50 mV from holding potentials ranging from −135 to −60 mV for 1 s (inset). (D, E) Alcohol WD produced a significant depolarizing shift in the inactivation curve of native T-type calcium current. The depolarizing shift was blocked by PKC peptide inhibitors, including PKC epsilon-specific inhibitors. (F) V 50 derived from the inactivation curve ~5 h. into the 4th alcohol WD in C57BL/6 mice was analyzed. The significant depolarizing shift for V 50 was blocked by the PKC peptide inhibitor (PKC (−), 10 μM). This inhibition was mimicked by specific PKCε isoform inhibitors (#530993, 539522; 5 μM) but not a PKCε translocation inhibitor inactive <t>peptide</t> <t>(#539542;</t> 5 μM). All drugs were delivered through the internal pipette solution. Statistics for V 50 showed F (6, 73) = 3.87, p = 0.0021 (One-Way ANOVA). In the plot * indicates p <0.05 and ** indicates p <0.01.
    Inactive Control, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/BAY-677/pmc11759478-81-10-22
    Average 92 stars, based on 1 article reviews
    inactive control - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier
    inactive control peptide (2 mm)  (GenScript corporation)
    90
    GenScript corporation inactive control peptide (2 mm)
    <t>PKC</t> mediates a T channel gain of function during alcohol withdrawal. (A–C) Representative traces of T-type current inactivation curves for (A) Air, (B) WD, and (C) WD + PKC (−) groups, respectively, elicited at −50 mV from holding potentials ranging from −135 to −60 mV for 1 s (inset). (D, E) Alcohol WD produced a significant depolarizing shift in the inactivation curve of native T-type calcium current. The depolarizing shift was blocked by PKC peptide inhibitors, including PKC epsilon-specific inhibitors. (F) V 50 derived from the inactivation curve ~5 h. into the 4th alcohol WD in C57BL/6 mice was analyzed. The significant depolarizing shift for V 50 was blocked by the PKC peptide inhibitor (PKC (−), 10 μM). This inhibition was mimicked by specific PKCε isoform inhibitors (#530993, 539522; 5 μM) but not a PKCε translocation inhibitor inactive <t>peptide</t> <t>(#539542;</t> 5 μM). All drugs were delivered through the internal pipette solution. Statistics for V 50 showed F (6, 73) = 3.87, p = 0.0021 (One-Way ANOVA). In the plot * indicates p <0.05 and ** indicates p <0.01.
    Inactive Control Peptide (2 Mm), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/inactive+control+peptide++2+mm+/pmc11343231-188-7-25
    Average 90 stars, based on 1 article reviews
    inactive control peptide (2 mm) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    chemicals, peptides, and recombinant proteins inactive degrader control  (Genentech inc)
    90
    Genentech inc chemicals, peptides, and recombinant proteins inactive degrader control
    <t>PKC</t> mediates a T channel gain of function during alcohol withdrawal. (A–C) Representative traces of T-type current inactivation curves for (A) Air, (B) WD, and (C) WD + PKC (−) groups, respectively, elicited at −50 mV from holding potentials ranging from −135 to −60 mV for 1 s (inset). (D, E) Alcohol WD produced a significant depolarizing shift in the inactivation curve of native T-type calcium current. The depolarizing shift was blocked by PKC peptide inhibitors, including PKC epsilon-specific inhibitors. (F) V 50 derived from the inactivation curve ~5 h. into the 4th alcohol WD in C57BL/6 mice was analyzed. The significant depolarizing shift for V 50 was blocked by the PKC peptide inhibitor (PKC (−), 10 μM). This inhibition was mimicked by specific PKCε isoform inhibitors (#530993, 539522; 5 μM) but not a PKCε translocation inhibitor inactive <t>peptide</t> <t>(#539542;</t> 5 μM). All drugs were delivered through the internal pipette solution. Statistics for V 50 showed F (6, 73) = 3.87, p = 0.0021 (One-Way ANOVA). In the plot * indicates p <0.05 and ** indicates p <0.01.
    Chemicals, Peptides, And Recombinant Proteins Inactive Degrader Control, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/chemicals++peptides++and+recombinant+proteins+inactive+degrader+control/pm38870012-238-103-128
    Average 90 stars, based on 1 article reviews
    chemicals, peptides, and recombinant proteins inactive degrader control - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    inactive isotype ctrl ab mouse igg1  (InvivoGen)
    95
    InvivoGen inactive isotype ctrl ab mouse igg1
    IL-6 was increased in the medium of mPDO + MAF co-cultures after C+P challenge and mediated increased OFA. ( A ) A Luminex-based assay for eight cytokines was used to detect inflammatory chemokines in the conditioned media of mPDO+MAF co-cultures. The histogram shows the average levels of the indicated cytokines from two independent experiments. ( B ) IL-6 is mainly secreted by MAFs after C+P. mPDOs, MAFs, and co-cultured mPDO+MAFs were assayed for IL-6 secretion 24 h after the C+P challenge by indirect ELISA. Results are expressed as fold-over controls, where controls are ctrl (vehicle)-treated cells. ( C ) Increased IL-6 may mediate the resistance of mPDOs to C+P. Y axis: OFA score (number of organoids formed/1000 live cells) was calculated in mPDO cultures challenged with ctrl (MAF-CM, not treated with C+P) or with MAF-CM (treated with C+P), in the presence of anti-IL-6 neutralising antibody <t>(IL-6-IgG)</t> or a control antibody (ctrl-IgG). Histograms represent the mean + SE of three independent experiments. Statistics: ** p < 0.01; ns = not significant.
    Inactive Isotype Ctrl Ab Mouse Igg1, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactive+control/Mouse+Control+IgG1/pmc11121414-181-10-19
    Average 95 stars, based on 1 article reviews
    inactive isotype ctrl ab mouse igg1 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    PKC mediates a T channel gain of function during alcohol withdrawal. (A–C) Representative traces of T-type current inactivation curves for (A) Air, (B) WD, and (C) WD + PKC (−) groups, respectively, elicited at −50 mV from holding potentials ranging from −135 to −60 mV for 1 s (inset). (D, E) Alcohol WD produced a significant depolarizing shift in the inactivation curve of native T-type calcium current. The depolarizing shift was blocked by PKC peptide inhibitors, including PKC epsilon-specific inhibitors. (F) V 50 derived from the inactivation curve ~5 h. into the 4th alcohol WD in C57BL/6 mice was analyzed. The significant depolarizing shift for V 50 was blocked by the PKC peptide inhibitor (PKC (−), 10 μM). This inhibition was mimicked by specific PKCε isoform inhibitors (#530993, 539522; 5 μM) but not a PKCε translocation inhibitor inactive peptide (#539542; 5 μM). All drugs were delivered through the internal pipette solution. Statistics for V 50 showed F (6, 73) = 3.87, p = 0.0021 (One-Way ANOVA). In the plot * indicates p <0.05 and ** indicates p <0.01.

    Journal: Alcohol, clinical & experimental research

    Article Title: Protein kinase C epsilon-mediated modulation of T-type calcium channels underlies alcohol withdrawal hyperexcitability in the midline thalamus

    doi: 10.1111/acer.15342

    Figure Lengend Snippet: PKC mediates a T channel gain of function during alcohol withdrawal. (A–C) Representative traces of T-type current inactivation curves for (A) Air, (B) WD, and (C) WD + PKC (−) groups, respectively, elicited at −50 mV from holding potentials ranging from −135 to −60 mV for 1 s (inset). (D, E) Alcohol WD produced a significant depolarizing shift in the inactivation curve of native T-type calcium current. The depolarizing shift was blocked by PKC peptide inhibitors, including PKC epsilon-specific inhibitors. (F) V 50 derived from the inactivation curve ~5 h. into the 4th alcohol WD in C57BL/6 mice was analyzed. The significant depolarizing shift for V 50 was blocked by the PKC peptide inhibitor (PKC (−), 10 μM). This inhibition was mimicked by specific PKCε isoform inhibitors (#530993, 539522; 5 μM) but not a PKCε translocation inhibitor inactive peptide (#539542; 5 μM). All drugs were delivered through the internal pipette solution. Statistics for V 50 showed F (6, 73) = 3.87, p = 0.0021 (One-Way ANOVA). In the plot * indicates p <0.05 and ** indicates p <0.01.

    Article Snippet: #539542 (Calbiochem) , PKCε Inactive peptide, negative control , WD vs WD + PKC inactive peptide , ns (p = 0.529), n = 24 , 4.26 ± 7.899.

    Techniques: Produced, Derivative Assay, Inhibition, Translocation Assay, Transferring

    Summary of inhibitors and results ( n = cell numbers).

    Journal: Alcohol, clinical & experimental research

    Article Title: Protein kinase C epsilon-mediated modulation of T-type calcium channels underlies alcohol withdrawal hyperexcitability in the midline thalamus

    doi: 10.1111/acer.15342

    Figure Lengend Snippet: Summary of inhibitors and results ( n = cell numbers).

    Article Snippet: #539542 (Calbiochem) , PKCε Inactive peptide, negative control , WD vs WD + PKC inactive peptide , ns (p = 0.529), n = 24 , 4.26 ± 7.899.

    Techniques: Translocation Assay, Negative Control

    Kinetic changes of T-channel during the application of PKC inhibitors recorded from the reuniens after 5 h into 4th alcohol withdrawal. (A, B) PKCε inhibitor (#530993, 5 μM) was applied through the bath solution, it significantly reduced rise time (A. paired t test, p = 0.0311, n = 6); increased rise slope (B. paired t test, p = 0.0266, n = 6); (C) Rise time did not show a significant main effect [ F (4, 53) = 2.205, p = 0.0809], although Dunnett’s post hoc test showed a significant difference between WD and WD plus PKCε (−), (#529522, p = 0.0223.* p <0.05). All drugs were delivered through the patch pipette internal solution, including the PKC peptide inhibitor (10 μM), and PKCε inhibitors (#530993, 5 μM; #539522, 5 μM).

    Journal: Alcohol, clinical & experimental research

    Article Title: Protein kinase C epsilon-mediated modulation of T-type calcium channels underlies alcohol withdrawal hyperexcitability in the midline thalamus

    doi: 10.1111/acer.15342

    Figure Lengend Snippet: Kinetic changes of T-channel during the application of PKC inhibitors recorded from the reuniens after 5 h into 4th alcohol withdrawal. (A, B) PKCε inhibitor (#530993, 5 μM) was applied through the bath solution, it significantly reduced rise time (A. paired t test, p = 0.0311, n = 6); increased rise slope (B. paired t test, p = 0.0266, n = 6); (C) Rise time did not show a significant main effect [ F (4, 53) = 2.205, p = 0.0809], although Dunnett’s post hoc test showed a significant difference between WD and WD plus PKCε (−), (#529522, p = 0.0223.* p <0.05). All drugs were delivered through the patch pipette internal solution, including the PKC peptide inhibitor (10 μM), and PKCε inhibitors (#530993, 5 μM; #539522, 5 μM).

    Article Snippet: #539542 (Calbiochem) , PKCε Inactive peptide, negative control , WD vs WD + PKC inactive peptide , ns (p = 0.529), n = 24 , 4.26 ± 7.899.

    Techniques: Transferring

    Midline thalamic neurons exhibit more spikes per low-threshold Ca 2+ burst during alcohol withdrawal. PKCε translocation inhibitor peptide (#539522) reduced the number of spikes/burst after 4th WD. (A–E) representative traces for the bursts elicited near resting membrane potential by prepulse negative current injection of −200 pA, 800 ms. (F) Statistics for the bursts induced by prepulse negative current injection of −200 pA. One-way ANOVA: F (4, 56) = 6.321, p = 0.0003, Dunnett’s multiple comparisons test, WD and Control, p = 0.0013; WD and Air exposed, p = 0.0461; WD and WD + PKCε (−), p = 0.0469; WD and WD + PKCε inactive peptide, p = 0.9990. In the plots * indicates p <0.05, and ** indicates p <0.01.

    Journal: Alcohol, clinical & experimental research

    Article Title: Protein kinase C epsilon-mediated modulation of T-type calcium channels underlies alcohol withdrawal hyperexcitability in the midline thalamus

    doi: 10.1111/acer.15342

    Figure Lengend Snippet: Midline thalamic neurons exhibit more spikes per low-threshold Ca 2+ burst during alcohol withdrawal. PKCε translocation inhibitor peptide (#539522) reduced the number of spikes/burst after 4th WD. (A–E) representative traces for the bursts elicited near resting membrane potential by prepulse negative current injection of −200 pA, 800 ms. (F) Statistics for the bursts induced by prepulse negative current injection of −200 pA. One-way ANOVA: F (4, 56) = 6.321, p = 0.0003, Dunnett’s multiple comparisons test, WD and Control, p = 0.0013; WD and Air exposed, p = 0.0461; WD and WD + PKCε (−), p = 0.0469; WD and WD + PKCε inactive peptide, p = 0.9990. In the plots * indicates p <0.05, and ** indicates p <0.01.

    Article Snippet: #539542 (Calbiochem) , PKCε Inactive peptide, negative control , WD vs WD + PKC inactive peptide , ns (p = 0.529), n = 24 , 4.26 ± 7.899.

    Techniques: Translocation Assay, Membrane, Injection, Control

    T-current-mediated bursting was elicited near resting membrane potential from a series of hyperpolarizing prepulse current injections. Using a procedure analogous to the voltage clamp inactivation protocol (current injections started from 0 to −400 pA, −50 pA step, 500 ms of duration), we measured T-current-mediated bursting. Control (A) and air-exposed (B) conditions elicit 1–3 action potentials/burst. After the 4th WD (C), the cells responded with increased numbers of spikes/burst, which were reduced by the PKC ε inhibitor (D) but not the PKC ε inhibitor inactive peptide (E).

    Journal: Alcohol, clinical & experimental research

    Article Title: Protein kinase C epsilon-mediated modulation of T-type calcium channels underlies alcohol withdrawal hyperexcitability in the midline thalamus

    doi: 10.1111/acer.15342

    Figure Lengend Snippet: T-current-mediated bursting was elicited near resting membrane potential from a series of hyperpolarizing prepulse current injections. Using a procedure analogous to the voltage clamp inactivation protocol (current injections started from 0 to −400 pA, −50 pA step, 500 ms of duration), we measured T-current-mediated bursting. Control (A) and air-exposed (B) conditions elicit 1–3 action potentials/burst. After the 4th WD (C), the cells responded with increased numbers of spikes/burst, which were reduced by the PKC ε inhibitor (D) but not the PKC ε inhibitor inactive peptide (E).

    Article Snippet: #539542 (Calbiochem) , PKCε Inactive peptide, negative control , WD vs WD + PKC inactive peptide , ns (p = 0.529), n = 24 , 4.26 ± 7.899.

    Techniques: Membrane, Control

    IL-6 was increased in the medium of mPDO + MAF co-cultures after C+P challenge and mediated increased OFA. ( A ) A Luminex-based assay for eight cytokines was used to detect inflammatory chemokines in the conditioned media of mPDO+MAF co-cultures. The histogram shows the average levels of the indicated cytokines from two independent experiments. ( B ) IL-6 is mainly secreted by MAFs after C+P. mPDOs, MAFs, and co-cultured mPDO+MAFs were assayed for IL-6 secretion 24 h after the C+P challenge by indirect ELISA. Results are expressed as fold-over controls, where controls are ctrl (vehicle)-treated cells. ( C ) Increased IL-6 may mediate the resistance of mPDOs to C+P. Y axis: OFA score (number of organoids formed/1000 live cells) was calculated in mPDO cultures challenged with ctrl (MAF-CM, not treated with C+P) or with MAF-CM (treated with C+P), in the presence of anti-IL-6 neutralising antibody (IL-6-IgG) or a control antibody (ctrl-IgG). Histograms represent the mean + SE of three independent experiments. Statistics: ** p < 0.01; ns = not significant.

    Journal: International Journal of Molecular Sciences

    Article Title: Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

    doi: 10.3390/ijms25105355

    Figure Lengend Snippet: IL-6 was increased in the medium of mPDO + MAF co-cultures after C+P challenge and mediated increased OFA. ( A ) A Luminex-based assay for eight cytokines was used to detect inflammatory chemokines in the conditioned media of mPDO+MAF co-cultures. The histogram shows the average levels of the indicated cytokines from two independent experiments. ( B ) IL-6 is mainly secreted by MAFs after C+P. mPDOs, MAFs, and co-cultured mPDO+MAFs were assayed for IL-6 secretion 24 h after the C+P challenge by indirect ELISA. Results are expressed as fold-over controls, where controls are ctrl (vehicle)-treated cells. ( C ) Increased IL-6 may mediate the resistance of mPDOs to C+P. Y axis: OFA score (number of organoids formed/1000 live cells) was calculated in mPDO cultures challenged with ctrl (MAF-CM, not treated with C+P) or with MAF-CM (treated with C+P), in the presence of anti-IL-6 neutralising antibody (IL-6-IgG) or a control antibody (ctrl-IgG). Histograms represent the mean + SE of three independent experiments. Statistics: ** p < 0.01; ns = not significant.

    Article Snippet: Neutralizing monoclonal antibody against human interleukin 6 and its biologically inactive isotype ctrl ab Mouse IgG1, kappa was from Invivogen (Invivogen, San Diego, CA, USA) and was used as indicated in the main text. mRNA extraction and expression analysis.

    Techniques: Luminex, Cell Culture, Indirect ELISA, Control